Delivery Room Practice Change Following the Initiation of the NICHD SUPPORT Trial

May 17, 2012 updated by: Luc Brion

This study was designed to analyze whether initiation of the NICHD Neonatal Research Network SUPPORT trial was followed by a change in frequency of endotracheal intubation the delivery room in non-participants and whether these changes were associated with changes in management and outcomes.

The investigators hypothesized that the investigators would observe following the initiation of the SUPPORT trial a 33% reduction in the rate of intubation in the delivery room among non-participants preterm infants at Parkland Memorial Hospital.

Study Overview

Status

Completed

Conditions

Study Type

Observational

Enrollment (Actual)

3843

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Texas
      • Dallas, Texas, United States, 75390-9063
        • University of Texas Southwestern

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

5 months to 8 months (Child)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

All babies born at Parkland Memorial Hospital with gestational age at least 24 weeks and less than 35 weeks between 01/2003 and 06/2010

Description

Inclusion Criteria:

  • All babies born at Parkland Memorial Hospital with gestational age at least 24 weeks and less than 35 weeks between 01/2003 and 06/2010

Exclusion Criteria:

  • Infants receiving comfort care
  • Those with major congenital anomalies
  • Those enrolled in the SUPPORT trial

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Before SUPPORT
01/03-06/05
During SUPPORT recruitment
07/05-02/09
After SUPPORT
03/09-06/10

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Endotracheal intubation in the delivery room
Time Frame: In the delivery room (1 day)
Frequency of endotracheal intubation in the delivery room
In the delivery room (1 day)

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Continuous positive airway pressure in the delivery room
Time Frame: In the delivery room (1 day)
Frequency of continuous positive airway pressure in the delivery room
In the delivery room (1 day)
Endotracheal intubation in the first four hours after admission
Time Frame: First four hours after admission
Frequency of endotracheal intubation in the first fours after admission to the neonatal intensive care unit
First four hours after admission
Endotracheal intubation until four hours after admission
Time Frame: Between birth and 4 hours after admission
Frequency of endotracheal intubation between birth and four hours after admission in the neonatal intensive care unit
Between birth and 4 hours after admission
Admninistration of surfactant
Time Frame: Any time between birth and 2 days of age
Frequency of admninistration of surfactant any time between birth and 2 days of age
Any time between birth and 2 days of age
Pneumothorax
Time Frame: Any time before discharge or transfer or 12 months of age (whichever comes first)
Pneumothorax any time before discharge or transfer or 12 months of age (whichever comes first)
Any time before discharge or transfer or 12 months of age (whichever comes first)
Bronchopulmonary dysplasia
Time Frame: 28 days
Chronic changes on chest radiograph and oxygen requirement (fractional inspiratory concentration of oxygen greater than 0.21) for at least 28 days
28 days
Necrotizing enterocolitis
Time Frame: Any time before discharge or transfer or 12 months of age (whichever comes first)
Necrotizing enterocolitis (at least stage II, modified Bell's classification) any time before discharge or transfer or 12 months of age (whichever comes first)
Any time before discharge or transfer or 12 months of age (whichever comes first)
Duration of mechanical ventilation
Time Frame: Until discharge or transfer or 12 months of age (whichever comes first)
Duration of invasive mechanical ventilation until discharge or transfer or or 12 months of age (whichever comes first)
Until discharge or transfer or 12 months of age (whichever comes first)
Maximum oxygen concentration
Time Frame: Until discharge or transfer or 12 months of age (whichever comes first)
Maximum inspiratory oxygen concentration until discharge or transfer or 12 months of age (whichever comes first)
Until discharge or transfer or 12 months of age (whichever comes first)
Severe retinopathy of prematurity
Time Frame: Until discharge or transfer or 12 months of age (whichever comes first)
Severe retinopathy of prematurity (at least stage III, international classification) until discharge or transfer or 12 months of age (whichever comes first)
Until discharge or transfer or 12 months of age (whichever comes first)
Mortality
Time Frame: Until discharge or transfer or 12 months of age (whichever comes first)
Mortality until discharge or transfer or 12 months of age (whichever comes first)
Until discharge or transfer or 12 months of age (whichever comes first)
Severe brain lesion on imaging
Time Frame: Any time before discharge or transfer or 12 months of age (whichever comes first)
Cystic periventricular leukomalacia or grade III or IV intraventricular/ periventricular hemorrhage detected by ultrasonogram any time before discharge or transfer or 12 months of age (whichever comes first)
Any time before discharge or transfer or 12 months of age (whichever comes first)

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Investigators

  • Principal Investigator: Luc P Brion, MD, University of Texas

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

April 1, 2008

Primary Completion (Actual)

November 1, 2011

Study Completion (Actual)

April 1, 2012

Study Registration Dates

First Submitted

May 15, 2012

First Submitted That Met QC Criteria

May 17, 2012

First Posted (Estimate)

May 18, 2012

Study Record Updates

Last Update Posted (Estimate)

May 18, 2012

Last Update Submitted That Met QC Criteria

May 17, 2012

Last Verified

May 1, 2012

More Information

Terms related to this study

Other Study ID Numbers

  • STU 092010-201
  • Velos 12121 (Other Identifier: University of Texas Southwestern)

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Preterm Birth

3
Subscribe